Location [1]
Chromatin remodeling/DNA methylation
Protein [2]
Methylcytosine dioxygenase TET2
Synonyms [1]

Tet methylcytosine dioxygenase 2 (TET2; also known as ten-eleven translocation 2) is a gene that codes for methylcytosine dioxygenase TET2, a protein involved in epigenetic regulation of myelopoeisis (Gene 2014PMID: 24220273). TET2 is a tumor suppressor, and so in cancer, loss of TET2 function, which can occur via TET2 mutation, TET2 deletion, or IDH1 or IDH2 mutation, can cause myeloid or lymphoid transformations (PMID: 24220273). Mutations in TET2 have been found in MDS, AML, ALL, and other hematologic malignancies.

TET2 is altered in 4.31% of all cancers with leukemia, non-small cell lung carcinoma, melanoma, colorectal adenocarcinoma, and myelodysplastic syndromes having the greatest prevalence of alterations [3].

TET2 GENIE Cases - Top Diseases

The most common alterations in TET2 are TET2 Mutation (4.45%), TET2 c.3310-c.4434 Missense (3.19%), TET2 c.3400-c.4331 Missense (3.19%), TET2 c.5524-c.5762 Missense (3.19%), and TET2 c.5533-c.6005 Missense (3.19%) [3].

TET2 GENIE Cases - Top Alterations

Significance of TET2 in Diseases

Acute Myeloid Leukemia +

Myelodysplastic Syndromes +

Malignant Solid Tumor +

Lymphoma +

Chronic Myelomonocytic Leukemia +

Myelodysplastic/Myeloproliferative Neoplasm +

Hepatoblastoma +

Melanoma +

Chronic Myeloid Leukemia +

Acute Lymphoblastic Leukemia +

Anaplastic Astrocytoma +

Bladder Carcinoma +

Non-Small Cell Lung Carcinoma +

Head And Neck Carcinoma +

Glioblastoma +

Colorectal Carcinoma +

Ovarian Carcinoma +

Retinoblastoma +

Breast Carcinoma +

Pancreatic Carcinoma +

Sarcoma +

Acute Biphenotypic Leukemia +

Acute Leukemia Of Ambiguous Lineage +

Mixed Phenotype Acute Leukemia +


1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20170629. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 4. This dataset does not represent the totality of the genetic landscape; see paper for more information.

4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.